COVID-19

Negative Patients

(n=69) [%]

COVID-19

Positive Patients

(n=9) [%]

p

Gender

            Males

            Females

22 (31.9%)

47 (68.1%)

6 (66.7%)

3 (33.3%)

0.04

Age (years, mean ± SD)

56 ± 18

69 ± 20

0.04

BMI (mean ± SD)

24 ± 4.2

25 ± 7

0.4

ASA score

            1

            2

            3

            4

25 (36.2%)

35 (50.7%)

8 (11.6%)

1 (1.5%)

2 (22.2%)

1 (11.1%)

6 (66.7%)

0

0.002

Comorbidities

            0-1

            2-4

56 (82.3%)

12 (17.7%)

4 (44.4%)

5 (55.6%)

0.02

Indication for Surgery

            Emergency

            Oncologic

            IBD

28 (40.6%)

35 (50.7%)

6 (8.7%)

5 (55.6%)

3 (33.3%)

1 (11.1%)

0.4

Surgical Access

            Open

            Laparoscopic

            Non-abdominal

11 (15.9%)

22 (31.9%)

36 (52.2%)

3 (33.3%)

4 (44.4%)

2 (22.3%)

0.1

Emergency

Urgent (Oncological, IBD)

29 (42%)

40 (58%)

6 (66.7%)

3 (33.3%)

0.2

Severe Complications

Clavien-Dindo III-IV

Clavien-Dindo V (Mortality) [4, 5]

2 (2.9%)

1 (1.4%)

5 (55.6%)

3 (33.3%)

0.0001

Postoperative Hospitalization (days)

5 ± 4

11 ± 7

0.0003